| 注册
首页|期刊导航|中国药物评价|基于CiteSpace的儿童清肺口服液相关研究可视化分析

基于CiteSpace的儿童清肺口服液相关研究可视化分析

钱灵娇 高敏 金孝博 郭慧娟 荣红国 鲁喦

中国药物评价2026,Vol.43Issue(2):106-111,6.
✕
中国药物评价2026,Vol.43Issue(2):106-111,6.

基于CiteSpace的儿童清肺口服液相关研究可视化分析

Visualization Analysis on Research Related to Children Qingfei Oral Liquid Based on CiteSpace

钱灵娇 1高敏 2金孝博 3郭慧娟 3荣红国 4鲁喦5

作者信息

  • 1. 北京中医药大学中医学院,北京 100029||北京中医药大学国际循证中医药研究院,北京 100029
  • 2. 北京同仁堂研究院,北京同仁堂股份有限公司科学研究所,北京 100079
  • 3. 北京同仁堂研究院,北京同仁堂科技发展股份有限公司制药厂,北京 100079
  • 4. 北京中医药大学国际循证中医药研究院,北京 100029
  • 5. 北京同仁堂研究院,北京同仁堂医养产业投资集团有限公司,北京 100062
  • 折叠

摘要

Abstract

Objective:To analyze the status,hotspots,and frontiers in the field of Children Qingfei Oral Liquid,to provide guidance for the clinical comprehensive evaluation of it.Methods:Relevant research literature on Children Qingfei Oral Liquid was retrieved from CNKI,VIP and WANFANG DATA.CiteSpace 6.1.R6 was utilized to conduct statistical analysis on authors,institutions,keywords.Results:A total of 65 research articles were included.The institution with the highest number of publications is Nanjing University of Chi-nese Medicine,with high-quality core journal articles are relatively limited.The research hotspots include combination therapy,clinical indications,and TCM syndromes,while the research frontier focuses on treatment of Mycoplasma pneumoniae pneumonia and cough due to food retention.Conclusion:Research on Children Qingfei Oral Liquid receive much attention.The clinical application scope of it should be expanded in the future,expecially regarding the thorough investigation into its therapeutic efficacy and safety,in order to refine the clinical comprehensive evaluation of Children Qingfei Oral Liquid.

关键词

儿童清肺口服液/CiteSpace/文献计量学/可视化分析

Key words

Children Qingfei oral liquid/CiteSpace/Bibliometry/Visual analysis

分类

医药卫生

引用本文复制引用

钱灵娇,高敏,金孝博,郭慧娟,荣红国,鲁喦..基于CiteSpace的儿童清肺口服液相关研究可视化分析[J].中国药物评价,2026,43(2):106-111,6.

基金项目

国家中医药管理局高水平中医药重点学科建设项目——中医药循证医学(zyyzdxk-2023249) (zyyzdxk-2023249)

国家中医药管理局课题(YGZXKT2024046) (YGZXKT2024046)

河北省中医药管理局课题(B2025019) (B2025019)

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文